Cargando…

Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?

In addition to its well-established role in embryo development, epithelial-to-mesenchymal transition (EMT) has been proposed as a general mechanism favoring tumor metastatization in several epithelial malignancies. Herein, we review the topic of EMT in cholangiocarcinoma (CCA), a primary liver cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brivio, Simone, Cadamuro, Massimiliano, Fabris, Luca, Strazzabosco, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693158/ https://www.ncbi.nlm.nih.gov/pubmed/26703747 http://dx.doi.org/10.3390/jcm4121958

Ejemplares similares

Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the “Reactive” Biliary Epithelial Phenotype
por: Fabris, Luca, et al.
Publicado: (2016)

Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness
por: Brivio, Simone, et al.
Publicado: (2017)

Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma
por: Cadamuro, Massimiliano, et al.
Publicado: (2017)

Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma
por: Cadamuro, Massimiliano, et al.
Publicado: (2022)

Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation
por: Morton, Stuart Duncan, et al.
Publicado: (2015)

New insights on the role of vascular endothelial growth factor in biliary pathophysiology
por: Mariotti, Valeria, et al.
Publicado: (2021)

The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases
por: Cadamuro, Massimiliano, et al.
Publicado: (2020)

Necroptosis in Cholangiocarcinoma
por: Sarcognato, Samantha, et al.
Publicado: (2020)

Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma
por: Cadamuro, Massimiliano, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma
por: Sawanyawisuth, Kanlayanee, et al.
Publicado: (2021)

In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?
por: Mohr, Raphael, et al.
Publicado: (2020)

Cholangiocarcinoma
por: Sarcognato, Samantha, et al.
Publicado: (2021)

MSI2 knockdown represses extrahepatic cholangiocarcinoma growth and invasion by inhibiting epithelial–mesenchymal transition
por: Hu, Feihu, et al.
Publicado: (2018)

CCR7 Mediates Cell Invasion and Migration in Extrahepatic Cholangiocarcinoma by Inducing Epithelial–Mesenchymal Transition
por: Oba, Mitsunobu, et al.
Publicado: (2023)

An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?
por: Armando, Federico, et al.
Publicado: (2022)

Are We Benign? What Can Wnt Signaling Pathway and Epithelial to Mesenchymal Transition Tell Us about Intracranial Meningioma Progression
por: Bukovac, Anja, et al.
Publicado: (2021)

Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients
por: Huang, Xiao-Yong, et al.
Publicado: (2014)

Periostin promotes malignant potential by induction of epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma
por: Mino, Masaaki, et al.
Publicado: (2017)

Epithelial-mesenchymal Transition and Cell Invasion
por: Son, Hwajin, et al.
Publicado: (2010)

Responses to Drought Stress in Poplar: What Do We Know and What Can We Learn?
por: Rosso, Laura, et al.
Publicado: (2023)

Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
por: Yao, Xing, et al.
Publicado: (2012)

FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells
por: Yang, Hui, et al.
Publicado: (2015)

Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma
por: Zhang, Tong-Jun, et al.
Publicado: (2017)

Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process
por: Dana, Paweena, et al.
Publicado: (2017)

Extracellular vesicle-encapsulated miR-30e suppresses cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition
por: Ota, Yu, et al.
Publicado: (2018)

M3 muscarinic acetylcholine receptors regulate epithelial–mesenchymal transition, perineural invasion, and migration/metastasis in cholangiocarcinoma through the AKT pathway
por: Feng, Yujie, et al.
Publicado: (2018)

FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling
por: Lu, Zhaoyang, et al.
Publicado: (2014)

Fascin Induces Epithelial-Mesenchymal Transition of Cholangiocarcinoma Cells by Regulating Wnt/β-Catenin Signaling
por: Mao, Xianhai, et al.
Publicado: (2016)

The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review
por: Kimawaha, Phongsaran, et al.
Publicado: (2023)

The Coming Coronavirus Crisis: What Can We Learn?
por: Lucchese, Matteo, et al.
Publicado: (2020)

Intrahepatic Cholangiocarcinoma Cells Promote Epithelial-mesenchymal Transition of Hepatocellular Carcinoma Cells by Secreting LAMC2
por: Cen, Wenda, et al.
Publicado: (2021)

Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022)

Can a fibrotic liver afford epithelial-mesenchymal transition?
por: Munker, Stefan, et al.
Publicado: (2017)

Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells
por: Di Matteo, Sabina, et al.
Publicado: (2021)

Cholangiocarcinoma and liver transplantation: What we know so far?
por: Safarpour, Ali Reza, et al.
Publicado: (2021)

CEACAM6 promotes cholangiocarcinoma migration and invasion by inducing epithelial-mesenchymal transition through inhibition of the SRC/PI3K/AKT signaling pathway
por: Liu, Chen, et al.
Publicado: (2022)

Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis
por: Pearson, Gray W.
Publicado: (2019)

Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
por: Wang, Yan, et al.
Publicado: (2018)

Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5
por: Yu, Z., et al.
Publicado: (2017)

GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma
por: Deng, Xiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0id1fhdhm4ebi9p4dd6k46fe58